Aerovate Therapeutics Analyst Ratings
BenzingaApr 2 00:05
Wells Fargo Maintains Overweight on Aerovate Therapeutics, Maintains $35 Price Target
BenzingaApr 2 00:07
Analysts Offer Insights on Healthcare Companies: Healthequity (HQY), Aerovate Therapeutics (AVTE) and Delcath Systems (DCTH)
TipRanksMar 27 18:10
Aerovate Therapeutics Analyst Ratings
BenzingaMar 25 20:37
Jefferies Assumes Aerovate Therapeutics at Buy, Raises Price Target to $65
BenzingaMar 25 20:39
TD Cowen Sticks to Its Buy Rating for Aerovate Therapeutics (AVTE)
TipRanksFeb 26 20:36
Aerovate Therapeutics (AVTE) Receives a Buy From BTIG
TipRanksJan 2 22:08
Buy Rating Affirmed: Aerovate Therapeutics' AV-101 Shows Strong Potential Amid Successful IMPAHCT Trial Progression
TipRanksNov 28, 2023 00:35
Analysts' Top Healthcare Picks: Aerovate Therapeutics (AVTE), Calidi Biotherapeutics (CLDI)
TipRanksNov 22, 2023 19:20
Analysts Offer Insights on Healthcare Companies: Adicet Bio (ACET) and Aerovate Therapeutics (AVTE)
TipRanksNov 14, 2023 14:50
TD Cowen Sticks to Their Buy Rating for Aerovate Therapeutics (AVTE)
TipRanksNov 13, 2023 23:16
Wedbush Adjusts Aerovate Therapeutics Price Target to $48 From $50, Maintains Outperform Rating
MT NewswiresAug 15, 2023 23:04
Analysts Are Bullish on Top Healthcare Stocks: Aerovate Therapeutics (AVTE), Antibe Therapeutics (ATBPF)
TipRanksAug 15, 2023 22:30
Aerovate Therapeutics (AVTE) Gets a Buy From Jefferies
TipRanksAug 15, 2023 21:05
Wedbush Lowers Aerovate Therapeutics' Price Target to $50 From $54, Keeps Outperform Rating
MT NewswiresMay 17, 2023 19:12
Aerovate Therapeutics (AVTE) Receives a Buy From Wedbush
TipRanksMay 17, 2023 18:55
Analysts Offer Insights on Healthcare Companies: LumiraDx (LMDX) and Aerovate Therapeutics (AVTE)
TipRanksMay 17, 2023 08:50
Analysts Offer Insights on Healthcare Companies: Prothena (PRTA), Y-Mabs Therapeutics (YMAB) and Aerovate Therapeutics (AVTE)
TipRanksApr 1, 2023 21:10
Aerovate Therapeutics (AVTE) Receives a Buy From Wedbush
TipRanksMar 30, 2023 21:36
Guggenheim Initiates Coverage On Aerovate Therapeutics With Buy Rating, Announces Price Target of $36
BenzingaMar 1, 2023 18:30
No Data
No Data